Hodaka Yamada

730 total citations
42 papers, 581 citations indexed

About

Hodaka Yamada is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Hodaka Yamada has authored 42 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Hodaka Yamada's work include Diabetes Treatment and Management (12 papers), Diabetes Management and Research (7 papers) and Pancreatic function and diabetes (7 papers). Hodaka Yamada is often cited by papers focused on Diabetes Treatment and Management (12 papers), Diabetes Management and Research (7 papers) and Pancreatic function and diabetes (7 papers). Hodaka Yamada collaborates with scholars based in Japan and United States. Hodaka Yamada's co-authors include Masafumi Kakei, San‐e Ishikawa, Masashi Yoshida, Kazuo Hara, Kiyonori Ito, Masanobu Kawakami, Katsuya Dezaki, Toshihiko Yada, Ikuyo Kusaka and Shin‐ichi Momomura and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes.

In The Last Decade

Hodaka Yamada

42 papers receiving 572 citations

Peers

Countries citing papers authored by Hodaka Yamada

Since Specialization

Citations

This map shows the geographic impact of Hodaka Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hodaka Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hodaka Yamada more than expected).

Fields of papers citing papers by Hodaka Yamada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hodaka Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hodaka Yamada. The network helps show where Hodaka Yamada may publish in the future.

Co-authorship network of co-authors of Hodaka Yamada

This figure shows the co-authorship network connecting the top 25 collaborators of Hodaka Yamada. A scholar is included among the top collaborators of Hodaka Yamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hodaka Yamada. Hodaka Yamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Retrospective Analysis of the Effectiveness of Oral Semaglutide in Type 2 Diabetes Mellitus and Its Effect on Cardiometabolic Parameters in Japanese Clinical Settings 2023 ·Journal of Cardiovascular Development and Disease ·Hodaka Yamada, Masashi Yoshida, (unknown), (unknown), (unknown), (unknown), Shuichi Nagashima, (unknown), (unknown), Kazuo Hara	18
2	Retrospective Study of IDegLira, a New Fixed-Ratio Combination, in Japanese Patients With Type 2 Diabetes Mellitus: Analysis of Background Factors Affecting Effectiveness After 6 Months of Treatment 2023 ·Journal of Clinical Medicine Research ·Hodaka Yamada, (unknown), (unknown), (unknown), (unknown), Masashi Yoshida, Shuichi Nagashima, Kazuo Hara	2
3	Teneligliptin, a DPP-4 Inhibitor, Improves Vascular Endothelial Function via Divergent Actions Including Changes in Circulating Endothelial Progenitor Cells 2023 ·Diabetes Metabolic Syndrome and Obesity ·(unknown), Tomio Umemoto, Hodaka Yamada, Takayuki Fujiwara, Kei Yamamoto, Yousuke Taniguchi, Kenichi Sakakura, Hiroshi Wada, Shin‐ichi Momomura, Hideo Fujita	7
4	Hypereosinophilia is a predictive biomarker of immune checkpoint inhibitor-induced hypopituitarism in patients with renal cell carcinoma 2022 ·BMC Endocrine Disorders ·Hodaka Yamada, Satoshi Washino, Daisuke Suzuki, (unknown), (unknown), (unknown), (unknown), Masashi Yoshida, Tsuzumi Konishi, Kimitoshi Saito, Tomoaki Miyagawa, Kazuo Hara	7
5	Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study 2022 ·Diabetes Therapy ·Hodaka Yamada, Masashi Yoshida, Daisuke Suzuki, (unknown), Shuichi Nagashima, (unknown), (unknown), Kazuo Hara	11
6	Spontaneous recovery of immune checkpoint inhibitor‐induced thyroiditis with high free T4 level: A case report 2021 ·SHILAP Revista de lepidopterología ·(unknown), Daisuke Suzuki, (unknown), (unknown), (unknown), Masashi Yoshida, Satoshi Washino, Tomoaki Miyagawa, Kazuo Hara, Hodaka Yamada	1
7	Adrenal crisis precipitated by influenza A led to the diagnosis of Sheehan's syndrome 18 years after postpartum hemorrhage 2020 ·SHILAP Revista de lepidopterología ·(unknown), Hitoshi Sugawara, Hodaka Yamada, (unknown), (unknown), Masashi Yoshida, Akira Ishii, Takahiko Fukuchi, Wilfred Y. Fujimoto	3
8	Sodium–glucose cotransporter 2 inhibitors improved time‐in‐range without increasing hypoglycemia in Japanese patients with type 1 diabetes: A retrospective, single‐center, pilot study 2020 ·Journal of Diabetes Investigation ·Daisuke Suzuki, Hodaka Yamada, Masashi Yoshida, (unknown), (unknown), (unknown), Kazuo Hara	17
9	Risk Factors of Hypoglycemic Encephalopathy and Prolonged Hypoglycemia in Patients With Severe Hypoglycemia 2019 ·Journal of Clinical Medicine Research ·(unknown), Hodaka Yamada, Daisuke Suzuki, (unknown), Yuko Matsumoto, (unknown), Masashi Yoshida, Hideo Toyoshima, Kazuo Hara	4
10	Background Factors Determining the Introduction and Dosage of Insulin in Women With Gestational Diabetes Mellitus 2019 ·Journal of Clinical Medicine Research ·Yuko Matsumoto, Hodaka Yamada, Masashi Yoshida, Daisuke Suzuki, (unknown), (unknown), (unknown), (unknown), Kenjiro Takagi, Kazuo Hara	2
11	High-density lipoprotein and apolipoprotein A-I inhibit palmitate-induced translocation of toll-like receptor 4 into lipid rafts and inflammatory cytokines in 3T3-L1 adipocytes 2017 ·Biochemical and Biophysical Research Communications ·Hodaka Yamada, Tomio Umemoto, Mikihiko Kawano, Masanobu Kawakami, Masafumi Kakei, Shin‐ichi Momomura, San‐e Ishikawa, Kazuo Hara	12
12	Eicosapentaenoic acid shows anti-inflammatory effect via GPR120 in 3T3-L1 adipocytes and attenuates adipose tissue inflammation in diet-induced obese mice 2017 ·Nutrition & Metabolism ·Hodaka Yamada, Tomio Umemoto, Masafumi Kakei, Shin‐ichi Momomura, Masanobu Kawakami, San‐e Ishikawa, Kazuo Hara	50
13	Effect of Liraglutide on Type B Insulin Resistance Syndrome and Insulin Allergy in Type 2 Diabetes: A Case Report 2017 ·Diabetes Therapy ·Yuko Matsumoto, Hodaka Yamada, (unknown), Daisuke Suzuki, Masafumi Kakei, Kazuo Hara	6
14	Relationship Between Angiopoietin-Like Protein 8 and Fasting Serum Triglyceride Level 2017 ·Journal of Clinical Medicine Research ·Hodaka Yamada, Ikuyo Kusaka, (unknown), Kazuo Hara, Masafumi Kakei, San‐e Ishikawa	7
15	Effects of a new bicarbonate/lactate-buffered neutral peritoneal dialysis fluid for peritoneal failure in patients undergoing peritoneal dialysis. 2016 ·PubMed ·Taro Hoshino, Hiroki Ishii, Taisuke Kitano, (unknown), Haruhisa Miyazawa, Hodaka Yamada, Kiyonori Ito, Yuichiro Ueda, Yoshio Kaku, Keiji Hirai, Honami Mori, Susumu Ookawara, Kaoru Tabei, Yoshiyuki Morishita	5
16	The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio Is a Useful Marker of Atherosclerosis in Early-Stage Chronic Kidney Disease 2016 ·PLoS ONE ·Hodaka Yamada, Makoto Kuro‐o, Kazuo Hara, Yuichiro Ueda, Ikuyo Kusaka, Masafumi Kakei, San-e Ishikawa	10
17	A Higher Cardiothoracic Ratio Is Associated with 2-Year Mortality after Hemodialysis Initiation 2015 ·SHILAP Revista de lepidopterología ·Kiyonori Ito, Susumu Ookawara, Yuichiro Ueda, Haruhisa Miyazawa, Hodaka Yamada, Sawako Goto, Hiroki Ishii, (unknown), Taisuke Kitano, Keiji Hirai, Masashi Yoshida, Yoshio Kaku, Taro Hoshino, (unknown), Honami Mori, Izumi Yoshida, Masafumi Kakei, Yoshiyuki Morishita, Kaoru Tabei	15
18	Lower 1,5-anhydroglucitol is associated with adverse clinical events after percutaneous coronary intervention 2015 ·Heart and Vessels ·Takayuki Fujiwara, Masashi Yoshida, (unknown), Hodaka Yamada, Takunori Tsukui, Tomohiro Nakamura, Kenichi Sakakura, Hiroshi Wada, (unknown), (unknown), Tomio Umemoto, Hiroshi Funayama, Yoshitaka Sugawara, Takeshi Mitsuhashi, Masafumi Kakei, Shin‐ichi Momomura, Junya Ako	8
19	Factors Affecting Cerebral Oxygenation in Hemodialysis Patients: Cerebral Oxygenation Associates with pH, Hemodialysis Duration, Serum Albumin Concentration, and Diabetes Mellitus 2015 ·PLoS ONE ·Kiyonori Ito, Susumu Ookawara, Yuichiro Ueda, Sawako Goto, Haruhisa Miyazawa, Hodaka Yamada, Taisuke Kitano, (unknown), Yoshio Kaku, Keiji Hirai, Masashi Yoshida, Taro Hoshino, (unknown), Honami Mori, Izumi Yoshida, Masafumi Kakei, Kaoru Tabei	42
20	Lower 1,5-anhydroglucitol is associated with denovo coronary artery disease in patients at high cardiovascular risk 2014 ·Heart and Vessels ·Takayuki Fujiwara, Masashi Yoshida, Hodaka Yamada, Takunori Tsukui, Tomohiro Nakamura, Kenichi Sakakura, Hiroshi Wada, (unknown), (unknown), Hiroshi Funayama, Yoshitaka Sugawara, Takeshi Mitsuhashi, Masafumi Kakei, Shin‐ichi Momomura, Junya Ako	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact